BioTelemetry is now
a Philips company
BioTelemetry’s remote monitoring services and clinical research capabilities expand the Philips patient care management offerings.
Philips acquired BioTelemetry, a leading provider of remote cardiac diagnostics and monitoring, in early 2021. BioTelemetry’s portfolio delivers the widest range of remote cardiac monitors with a unique cardiac data platform, AI-based data analytics for chronic disease management and clinical trial services.
“With our collective portfolios, and our healthcare informatics and services platforms, we will be in an optimal position to improve patient care across care settings for multiple diseases and medical conditions.”
Frans van Houten
CEO of Royal Philips
Access your account, product and services information
Capabilities that can advance care and streamline workflow
Extend cardiac diagnostics, monitoring and analytics from hospital to home. Eliminate care obstacles for patients living with chronic conditions. And keep your trials on track.
BioTel Heart delivers a broad portfolio of remote monitoring devices, with services to help you streamline workflow and improve patient care with actionable insights, robust analysis and time-saving management solutions.
BioTel Care delivers remote patient monitoring and population health management capabilities for chronic conditions, including diabetes, hypertension and heart failure.
BioTel Research conducts centralized medical imaging and cardiac safety testing for clinical trials.
We integrate remote care models into your workflow to:
Talk with us about how we can help you manage cardiac care, chronic disease and clinical research.
Spotlight on:
Extended Wear Holter Monitoring ePatch®
Resources
Explore more services and solutions from Philips
Frequently asked questions
- Which BioTelemetry businesses are now part of Philips?
-
BioTelemetry’s BioTel Heart, BioTel Care, BioTel Research and BioTel Alliance businesses are part of Philips Connected Care business group.
- Will my contact at BioTel change?
-
In the short term, Philips and BioTelemetry will continue to operate as separate businesses and your primary sales contact will remain your point of contact. There will be no changes to the level of service you come to expect from BioTel Heart, BioTel Care, BioTel Research or BioTel Alliance. We will inform you well in advance of any changes to your account management that may arise during the integration process. If you have any further questions, please do not hesitate to contact your sales rep directly, call 888.312.2328 or email with questions.
- Will there be changes to the clinical trial services portfolio?
-
Yes, we will be expanding our global reach with upcoming services and devices that we can offer our customers.
- How does BioTelemetry integrate into the Philips portfolio?
-
Philips’ current portfolio includes real-time patient monitoring, therapeutic devices, telehealth and informatics. Also, Philips has an advanced and secure cloud-based Philips HealthSuite digital platform optimized for the delivery of healthcare across care settings. Every year, Philips’ integrated solutions monitor around 300 million patients in hospitals, as well as around 10 million sleep and respiratory care patients in their own homes.
- Who do I talk about clinical trial services?
-
Email BioTel Research at BTR@gobio.com for more information.
- How will this integration affect my current and future clinical trials?
-
We do not anticipate any major adjustments. You will work with your dedicated project manager and communications will be made throughout the transition.
Support
We’re here to help! How would you like to connect with us?
BIOTEL HEART US Direct Sales
Phone: 1-586-292-4366
Toll-Free: 1-888-324-8041
BTA-US@gobio.com
BIOTEL INTERNATIONAL
Sweden: +468-86 88 80
BIOTEL CARE
1-888-666-4530
Customercare@gobio.com
BIOTEL RESEARCH Toll-Free: 1-877-324-8326
CLINICAL TRIALS SUPPORT
BTRsupport@gobio.com
